MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹46.34 | ₹48.25 | ₹47.75 | ₹32.00 | ₹35.78 |
What is the latest Earnings Per Share (EPS) of MANKIND PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹46.34 |
| Mar2025 | ₹48.25 |
| Mar2024 | ₹47.75 |
| Mar2023 | ₹32.00 |
| Mar2022 | ₹35.78 |
How is Earnings Per Share (EPS) of MANKIND PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹46.34 | -3.96 | |
| Mar2025 | ₹48.25 | 1.05 | |
| Mar2024 | ₹47.75 | 49.22 | |
| Mar2023 | ₹32.00 | -10.56 | |
| Mar2022 | ₹35.78 | - | |
Compare Earnings Per Share (EPS) of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹101,647.6 Cr | 11% | 0.9% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 11% |
0.9% |
1.4% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses